Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Cytosorbents (CTSO) Return on Sales (2016 - 2025)

Cytosorbents' Return on Sales history spans 15 years, with the latest figure at 0.7% for Q4 2025.

  • Quarterly results put Return on Sales at 0.7% for Q4 2025, down 116.0% from a year ago — trailing twelve months through Dec 2025 was 0.42% (down 17.0% YoY), and the annual figure for FY2025 was 0.25%, changed 0.0%.
  • Return on Sales for Q4 2025 was 0.7% at Cytosorbents, down from 0.33% in the prior quarter.
  • In the past five years, Return on Sales ranged from a high of 1.77% in Q4 2023 to a low of 1.5% in Q3 2022.
  • The 5-year median for Return on Sales is 0.56% (2023), against an average of 0.48%.
  • The sharpest move saw Return on Sales surged 185bps in 2023, then tumbled -132bps in 2024.
  • Year by year, Return on Sales stood at 0.86% in 2021, then surged by 91bps to 0.08% in 2022, then surged by 2269bps to 1.77% in 2023, then crashed by -74bps to 0.45% in 2024, then crashed by -255bps to 0.7% in 2025.
  • According to Business Quant data, Return on Sales over the past three periods came in at 0.7%, 0.33%, and 0.44% for Q4 2025, Q3 2025, and Q2 2025 respectively.